Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
In vitro, DSIP has a half-life of approximately 15 minutes due to the action of a specific aminopeptidase-like enzyme
Rather than taking a one-size-fits-all approach, we take the time to understand your goals and build a plan around you, helping you make informed, confident decisions about B12 injections
Whether this is due to cumulative immune modulation or other factors is unclear
Ultimately, healthcare providers recognize that optimal GLP-1 timing is a collaborative decision
Like other incretin-based medications, the most common side effects were gastrointestinal: Common Side Effects Nausea: Reported in approximately 25-45% of participants depending on dose (most common during titration) Diarrhea: Approximately 20-35% of participants Vomiting: Approximately 10-20% of participants Constipation: Approximately 10-15% of participants Decreased appetite: Common and expected given the mechanism of action Less Common but Notable Effects Increased heart rate: Small elevations in resting heart rate were observed, consistent with other GLP-1 class medications Injection site reactions: Mild redness or itching at injection sites Fatigue: Reported by some participants, particularly during dose escalation Most adverse events were mild to moderate and occurred primarily during the dose escalation phase
Presented for research literature review only Drge W et al
